Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
217
days
Circulating Tumor DNA and Immune Response Markers for Improved Treatment Outcome Prediction in Diffuse Large B‐Cell Lymphoma: A Scoping Review
Authors
Ailin McMahon; Elizabeth J. Ryan; Sarah Dillon; Ruth CliffordShow moreShow less
Affiliations
1. Department of Haematology University Hospital Limerick Limerick Ireland; 2. Limerick Digital Cancer Research Centre Health Research Institute (HRI) University of Limerick Limerick IrelandShow moreShow less
144
days
Venetoclax in Combination With Chemo‐Immunotherapy in Richter Transformation: A Real‐Life Experience
Authors
L. Ballotta; J. Olivieri; D. Facchinelli; I. Ferrarini; A. Visentin; R. Moia; M. Cavallari; V. Innao; E. Derenzini; P. M. Nierychlewska; A. Cuda; V. Gattei; M. Ballerini; E. Lucchini; M. Turoldo; M. C. Rossetti; F. Gaudio; F. ZajaShow moreShow less
Affiliations
1. UCO Ematologia ASUGI Azienda Sanitaria Universitaria Giuliano Isontina Ospedale Maggiore Trieste Trieste Italy; 2. Clinica di Ematologia Centro Trapianti e Terapie Cellulari Carlo Melzi ASUFC—Azienda Sanitaria Universitaria Friuli Centrale—Ospedale Civile “Santa Maria della Misericordia” Udine Udine Italy; 3. UOC Ematologia ULSS8 Ospedale San Bortolo di Vicenza Vicenza Italy; 4. Hematology Unit Section of Biomedicine of Innovation Department of Engineering for Innovation Medicine University of Verona Verona Italy; 5. U.O. di Ematologia Dipartimento di Medicina Università di Padova Padova Italy; 6. Divisione di Ematologia Dipartimento di Medicina Traslazionale Università del Piemonte Orientale Novara Italy; 7. U.O. Ematologia ULSS3 Serenissima Ospedale dell'Angelo Venezia Italy; 8. U.O.C Ematologia A.R.N.A.S. Garibaldi Catania Italy; 9. Divisione di Oncoematologia Istituto Europeo Oncologico (IEO) Milano Italy; 10. SC Direzione Medica Cattinara e Maggiore ASUGI Azienda Sanitaria Universitaria Giuliano Isontina Trieste Italy; 11. Centro di Riferimento Oncologico (CRO) IRCCS SOC Onco‐Ematologia Clinico Sperimentale Aviano Italy; 12. Clinical Research Coordinator UCO Ematologia ASUGI Azienda Sanitaria Universitaria Giuliano Isontina Ospedale Maggiore Trieste Trieste Italy; 13. Department of Medicine and Surgery LUM University “Giuseppe Degennaro” Casamassima Italy; 14. Hematology Unit ‐ Ecclesiastical Entity Regional General Hospital “F. Miulli” Acquaviva delle Fonti Italy; 15. Dipartimento Universitario Clinico di Scienze Mediche Chirurgiche e della Salute Università di Trieste Trieste ItalyShow moreShow less
108
days
Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series
Authors
Stephanie Quon; Yaswanta Gummadi; Ibrahim Elsharawi; Jessica Dobson; Mariam Goubran; Ryan J. Stubbins; Eli L. Diamond; Luke Y. C. ChenShow moreShow less
Affiliations
1. Faculty of Medicine University of British Columbia Vancouver British Columbia Canada; 2. Department of Medicine Dalhousie University Halifax Nova Scotia Canada; 3. Department of Pathology Dalhousie University Halifax Nova Scotia Canada; 4. Department of Diagnostic Radiology Dalhousie University Halifax Nova Scotia Canada; 5. Division of Hematology University of British Columbia Vancouver British Columbia Canada; 6. Coastal Rare Inflammatory Diseases Program Halifax Nova Scotia Canada; 7. Department of Neurology Memorial Sloan Kettering Cancer Center New York New York USA; 8. Division of Hematology Dalhousie University Halifax Nova Scotia CanadaShow moreShow less
173
days
Allogeneic Stem Cell Transplantation—A Salvage Option for High‐Risk Chronic Lymphocytic Leukemia Patients: A 15‐Year Single‐Center Experience
Authors
Natalia B. Mikhailova; Maria I. Kislova; Maria O. Ivanova; Julia A. Zhuravleva; Elena A. Dmitrieva; Elena V. Kondakova; Anna G. Smirnova; Yana V. Krylova; Olga V. Kudyasheva; Yulia Y. Vlasova; Anastasya V. Beynarovich; Nikita P. Volkov; Ivan S. Moiseev; Eugene A. Nikitin; Alexander D. KulaginShow moreShow less
Affiliations
1. R.M.Gorbacheva Research Institute Pavlov University Saint‐Petersburg Russia; 2. Botkin Hospital Moscow RussiaShow moreShow less
62
days
Targeting a CDH1–TK1–dependent DNA Synthesis Pathway Overcomes Chemoresistance in Acute Myeloid Leukemia
Authors
Xiaomin Feng; Li Huo; Clifford Pang; Zhihang Jiang; Yujuan Xue; Huimin ZengShow moreShow less
Affiliations
1. Clinical Research Centre Guangdong Clifford Hospital Guangzhou China; 2. Joe R. and Teresa Lozano Long School of Medicine UT Health San Antonio Mays Cancer Center San Antonio Texas USA; 3. Department of Hematology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China; 4. Guangzhou Wellness Stem Cell Research Co. Ltd. Guangzhou China; 5. Department of Gastroenterology The First Affiliated Hospital of Chongqing Medical University Chongqing China; 6. Department of Pediatrics Peking University People's Hospital Peking University Beijing ChinaShow moreShow less
217
days
Studying Chronic Lymphocytic Leukemia Microenvironment in the Multi Omics Era
Authors
Bucci Antonella; Notarpietro Giulia; Apollonio Benedetta; Vegliante Maria Carmela; Pappagallo Susanna Anita; Mondelli Paolo; Scattone Anna; Donati Benedetta; Ponzoni Maurilio; Frenquelli Michela; Ghia Paolo; Minoia CarlaShow moreShow less
Affiliations
1. Hematology and Cell Therapy Unit IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 2. Rare Tumors and Melanoma Unit IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 3. Pathology Unit IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 4. Laboratory of Translational Research Azienda Unità Sanitaria Locale—IRCCS di Reggio Emilia Reggio Emilia Italy; 5. Pathology Unit San Raffaele Scientific Institute Milan Italy; 6. Università Vita‐Salute San Raffaele Medical School Milano Italy; 7. IRCCS Ospedale San Raffaele B‐cell Neoplasia Unit Comprehensive Cancer Center Milano ItalyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days